Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127878741 | 12787874 | 1 | I | 2016 | 20160913 | 20160928 | 20160928 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-077069 | BRISTOL MYERS SQUIBB | 47.79 | YR | M | Y | 0.00000 | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127878741 | 12787874 | 1 | PS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | U | 9218 | ||||||||||
| 127878741 | 12787874 | 2 | SS | ORENITRAM | TREPROSTINIL | 1 | Oral | 1.25 MG, TID | 18.7579994 | MG | Y | 2100476,2100477 , 2100679 | 0 | 1.25 | MG | TABLET | TID | ||
| 127878741 | 12787874 | 3 | SS | TYVASO | TREPROSTINIL | 1 | Respiratory (inhalation) | 1 DF, QID | 1.864 | MG | Y | 2100747 | 0 | 1 | DF | QID | |||
| 127878741 | 12787874 | 4 | SS | TYVASO | TREPROSTINIL | 1 | Respiratory (inhalation) | 1 DF, QID | 1.864 | MG | Y | 2100760 | 0 | 1 | DF | QID | |||
| 127878741 | 12787874 | 5 | SS | TYVASO | TREPROSTINIL | 1 | Respiratory (inhalation) | 1 DF, QID | 1.864 | MG | Y | 200810 | 0 | 1 | DF | QID | |||
| 127878741 | 12787874 | 6 | SS | TYVASO | TREPROSTINIL | 1 | Oral | 0.125 MG, TID | 1.864 | MG | Y | 0 | .125 | MG | TID | ||||
| 127878741 | 12787874 | 7 | SS | TYVASO | TREPROSTINIL | 1 | Oral | 2.5 MG, TID | 1.864 | MG | Y | 0 | 2.5 | MG | TID | ||||
| 127878741 | 12787874 | 8 | SS | AMOXICILLIN. | AMOXICILLIN | 1 | Unknown | U | 0 | ||||||||||
| 127878741 | 12787874 | 9 | C | MACITENTAN | MACITENTAN | 1 | Unknown | 10 MG, UNK | U | 0 | 10 | MG | |||||||
| 127878741 | 12787874 | 10 | C | TORSEMIDE. | TORSEMIDE | 1 | Unknown | 100 MG, QD | U | 0 | 100 | MG | QD | ||||||
| 127878741 | 12787874 | 11 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | 100 MG, UNK | U | 0 | 100 | MG | |||||||
| 127878741 | 12787874 | 12 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | Y | 0 | ||||||||||
| 127878741 | 12787874 | 13 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | 25 MG, UNK | U | 0 | 25 | MG | |||||||
| 127878741 | 12787874 | 14 | C | COREG | CARVEDILOL | 1 | Unknown | 12.5 MG, BID | U | 0 | 12.5 | MG | BID | ||||||
| 127878741 | 12787874 | 15 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | U | 0 | ||||||||||
| 127878741 | 12787874 | 16 | C | LIDOCAINE. | LIDOCAINE | 1 | Unknown | U | 0 | ||||||||||
| 127878741 | 12787874 | 17 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | UNK, PRN | U | 0 | |||||||||
| 127878741 | 12787874 | 18 | C | SENNOSIDE A+B | SENNOSIDES A AND B | 1 | Unknown | U | 0 | ||||||||||
| 127878741 | 12787874 | 19 | C | PERCOCET /00446701/ | ACETAMINOPHENOXYCODONE HYDROCHLORIDEOXYCODONE TEREPHTHALATE | 1 | Unknown | U | 0 | ||||||||||
| 127878741 | 12787874 | 20 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | U | 0 | ||||||||||
| 127878741 | 12787874 | 21 | C | REVATIO | SILDENAFIL CITRATE | 1 | Unknown | 20 MG, TID | U | 0 | 20 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127878741 | 12787874 | 1 | Product used for unknown indication |
| 127878741 | 12787874 | 2 | Pulmonary hypertension |
| 127878741 | 12787874 | 3 | Pulmonary hypertension |
| 127878741 | 12787874 | 8 | Product used for unknown indication |
| 127878741 | 12787874 | 9 | Product used for unknown indication |
| 127878741 | 12787874 | 10 | Product used for unknown indication |
| 127878741 | 12787874 | 11 | Product used for unknown indication |
| 127878741 | 12787874 | 12 | Product used for unknown indication |
| 127878741 | 12787874 | 13 | Product used for unknown indication |
| 127878741 | 12787874 | 14 | Product used for unknown indication |
| 127878741 | 12787874 | 15 | Product used for unknown indication |
| 127878741 | 12787874 | 16 | Product used for unknown indication |
| 127878741 | 12787874 | 17 | Product used for unknown indication |
| 127878741 | 12787874 | 18 | Product used for unknown indication |
| 127878741 | 12787874 | 19 | Product used for unknown indication |
| 127878741 | 12787874 | 20 | Product used for unknown indication |
| 127878741 | 12787874 | 21 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127878741 | 12787874 | OT |
| 127878741 | 12787874 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127878741 | 12787874 | Cellulitis | |
| 127878741 | 12787874 | Contusion | |
| 127878741 | 12787874 | Cough | |
| 127878741 | 12787874 | Decreased appetite | |
| 127878741 | 12787874 | Exercise tolerance decreased | |
| 127878741 | 12787874 | Fatigue | |
| 127878741 | 12787874 | Flushing | |
| 127878741 | 12787874 | Headache | |
| 127878741 | 12787874 | Increased tendency to bruise | |
| 127878741 | 12787874 | International normalised ratio decreased | |
| 127878741 | 12787874 | Nasal discharge discolouration | |
| 127878741 | 12787874 | Nausea | |
| 127878741 | 12787874 | Pain in extremity | |
| 127878741 | 12787874 | Sepsis | |
| 127878741 | 12787874 | Sinus congestion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127878741 | 12787874 | 2 | 20160119 | 20160623 | 0 | |
| 127878741 | 12787874 | 3 | 20140417 | 0 | ||
| 127878741 | 12787874 | 4 | 20160513 | 0 | ||
| 127878741 | 12787874 | 6 | 20160119 | 20160317 | 0 | |
| 127878741 | 12787874 | 7 | 20160317 | 0 |